Annual Operating Profit:
-$479.00M-$128.94M(-36.83%)Summary
- As of today, RXRX annual operating income is -$479.00 million, with the most recent change of -$128.94 million (-36.83%) on December 31, 2024.
- During the last 3 years, RXRX annual operating profit has fallen by -$296.23 million (-162.07%).
- RXRX annual operating profit is now -667.13% below its all-time high of -$62.44 million, reached on December 31, 2019.
Performance
RXRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Profit:
-$176.23M+$15.14M(+7.91%)Summary
- As of today, RXRX quarterly operating income is -$176.23 million, with the most recent change of +$15.14 million (+7.91%) on June 30, 2025.
- Over the past year, RXRX quarterly operating profit has dropped by -$75.68 million (-75.28%).
- RXRX quarterly operating profit is now -867.38% below its all-time high of -$18.22 million, reached on June 30, 2020.
Performance
RXRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Operating Profit:
-$649.72M-$75.68M(-13.18%)Summary
- As of today, RXRX TTM operating income is -$649.72 million, with the most recent change of -$75.68 million (-13.18%) on June 30, 2025.
- Over the past year, RXRX TTM operating profit has dropped by -$254.35 million (-64.33%).
- RXRX TTM operating profit is now -3442.04% below its all-time high of -$18.34 million, reached on March 31, 2020.
Performance
RXRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RXRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -36.8% | -75.3% | -64.3% |
| 3Y3 Years | -162.1% | -166.2% | -178.2% |
| 5Y5 Years | -667.1% | -867.4% | -1000.6% |
RXRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -162.1% | at low | -189.0% | +7.9% | -164.4% | at low |
| 5Y | 5-Year | -667.1% | at low | -684.1% | +7.9% | -1000.6% | at low |
| All-Time | All-Time | -667.1% | at low | -867.4% | +7.9% | -3442.0% | at low |
RXRX Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$176.23M(+7.9%) | -$649.72M(-13.2%) |
| Mar 2025 | - | -$191.37M(-4.1%) | -$574.03M(-19.8%) |
| Dec 2024 | -$479.00M(-36.8%) | -$183.77M(-86.8%) | -$479.00M(-21.5%) |
| Sep 2024 | - | -$98.35M(+2.2%) | -$394.17M(+0.3%) |
| Jun 2024 | - | -$100.54M(-4.4%) | -$395.36M(-5.0%) |
| Mar 2024 | - | -$96.34M(+2.6%) | -$376.54M(-7.6%) |
| Dec 2023 | -$350.06M(-42.5%) | -$98.93M(+0.6%) | -$350.06M(-12.2%) |
| Sep 2023 | - | -$99.55M(-21.8%) | -$312.11M(-13.4%) |
| Jun 2023 | - | -$81.72M(-17.0%) | -$275.13M(-6.0%) |
| Mar 2023 | - | -$69.86M(-14.6%) | -$259.61M(-5.7%) |
| Dec 2022 | -$245.73M | -$60.98M(+2.5%) | -$245.73M(+1.6%) |
| Sep 2022 | - | -$62.57M(+5.5%) | -$249.71M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$66.19M(-18.2%) | -$233.53M(-12.1%) |
| Mar 2022 | - | -$55.98M(+13.8%) | -$208.27M(-13.9%) |
| Dec 2021 | -$182.78M(-116.0%) | -$64.96M(-40.0%) | -$182.78M(-27.5%) |
| Sep 2021 | - | -$46.40M(-13.4%) | -$143.40M(-20.0%) |
| Jun 2021 | - | -$40.93M(-34.3%) | -$119.47M(-23.5%) |
| Mar 2021 | - | -$30.48M(-19.2%) | -$96.76M(-14.3%) |
| Dec 2020 | -$84.61M(-35.5%) | - | - |
| Dec 2020 | - | -$25.58M(-13.8%) | -$84.61M(-43.3%) |
| Sep 2020 | - | -$22.47M(-23.4%) | -$59.03M(-61.5%) |
| Jun 2020 | - | -$18.22M(+0.7%) | -$36.56M(-99.3%) |
| Mar 2020 | - | -$18.34M | -$18.34M |
| Dec 2019 | -$62.44M | - | - |
FAQ
- What is Recursion Pharmaceuticals, Inc. annual operating income?
- What is the all-time high annual operating profit for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. annual operating profit year-on-year change?
- What is Recursion Pharmaceuticals, Inc. quarterly operating income?
- What is the all-time high quarterly operating profit for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
- What is Recursion Pharmaceuticals, Inc. TTM operating income?
- What is the all-time high TTM operating profit for Recursion Pharmaceuticals, Inc.?
- What is Recursion Pharmaceuticals, Inc. TTM operating profit year-on-year change?
What is Recursion Pharmaceuticals, Inc. annual operating income?
The current annual operating profit of RXRX is -$479.00M
What is the all-time high annual operating profit for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high annual operating income is -$62.44M
What is Recursion Pharmaceuticals, Inc. annual operating profit year-on-year change?
Over the past year, RXRX annual operating income has changed by -$128.94M (-36.83%)
What is Recursion Pharmaceuticals, Inc. quarterly operating income?
The current quarterly operating profit of RXRX is -$176.23M
What is the all-time high quarterly operating profit for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high quarterly operating income is -$18.22M
What is Recursion Pharmaceuticals, Inc. quarterly operating profit year-on-year change?
Over the past year, RXRX quarterly operating income has changed by -$75.68M (-75.28%)
What is Recursion Pharmaceuticals, Inc. TTM operating income?
The current TTM operating profit of RXRX is -$649.72M
What is the all-time high TTM operating profit for Recursion Pharmaceuticals, Inc.?
Recursion Pharmaceuticals, Inc. all-time high TTM operating income is -$18.34M
What is Recursion Pharmaceuticals, Inc. TTM operating profit year-on-year change?
Over the past year, RXRX TTM operating income has changed by -$254.35M (-64.33%)